Microgestin 1/20 Kit
Product Images NDC 51862-868

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Microgestin 1/20 (NDC 51862-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram showing Norethindrone Acetate on the left and Ethinyl Estradiol on the right, the active ingredients in Microgestin 1/20 by Mayne Pharma Inc.*

FDA Label Image

2 (Image 02)

A data table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method,' showing percentages of women experiencing unintended pregnancy with various contraceptive methods. Methods listed include no contraception, oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, abstinence, withdrawal, and sterilization. The table compares lowest expected and typical failure rates.*

FDA Label Image

3 (Image 03)

A boxed warning panel highlighting the increased risk of serious cardiovascular side effects for women using oral contraceptives who smoke cigarettes, especially those over 35 years old or heavy smokers (15 or more cigarettes per day). It strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' The chart shows mortality rates by age groups (15-24, 25-34, 35-44, 45-) for four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). Mortality rates increase with age, especially among smokers who are ever-users, with the highest rates in the 45 and older group.*

FDA Label Image

5 (Image 05)

A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility per 100,000 Nonsterile Women by Fertility Control Method According to Age.' It categorizes death rates by fertility control method (e.g., no fertility control, oral contraceptives non-smoker, oral contraceptives smoker, IUD, condom, diaphragm/spermicide, periodic abstinence) and age groups ranging from 15-19 to 40-44 years. The table distinguishes between birth-related and method-related deaths.*

FDA Label Image

6 (Image 06)

A boxed warning stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with this risk rising with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years. It strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

An instructional diagram showing a hand holding a Microgestin 1/20 pill kit with all pale yellow pills. The diagram includes instructions for placing a day label sticker corresponding to the start day of the period, indicating where to start for Sunday or Day 1 starters, and arrows showing to take pills from left to right. It highlights 3 active pale yellow pills as an example.*

FDA Label Image

8 (Image 08)

A warning box stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with higher risk in women over 35 years old and heavy smokers (15 or more cigarettes per day). It advises women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

Data table showing annual number of birth-related or method-related deaths associated with fertility control per 100,000 nonsterile women by fertility control method and age group. Methods include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, detailed across age ranges 15-19 to 40-44.*

FDA Label Image

10 (Image 10)

An instructional illustration for Microgestin 1/20 containing pale yellow active pills. It shows a pack of birth control pills with a day label sticker being applied on top to align with the start day of the period. Instructions include starting the pills either on the Sunday starter or day 1 starter, with pill-taking direction indicated left to right across the pack.*

FDA Label Image

11 (Image 11)

FDA Label Image

12 (Image 12)

Microgestin 1/20 (Norethindrone Acetate and Ethinyl Estradiol) tablets kit packaging label distributed by Mayne Pharma Inc. The label shows the product name and strength, active ingredients, dosage form as tablets, and package details indicating 6 blister cards of 21 tablets each. It includes storage instructions, prescription use note, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.